US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
TSXV
Cytophage Technologies Ltd (CYTO) 銘柄情報

Cytophage Technologies Ltd (CYTO)

0.005

0.00

( 0.00% )

更新日時： 09:00:00

Cytophage Technologies Ltd (CYTO) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.005

( - )

買値

0.005

売値

0.005

出来高

-

0.00 日の範囲 0.00

0.005 52 週間の範囲 0.32

時価総額

前日終値

0.005

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 0

発行済株式数

64,886,733

配当利回り

PER

-

1 株当たり利益 (EPS)

-0.07

歳入

-

純利益

-4.13M

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; foo... Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name. The company is headquartered in Oak Bluff, Canada. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

cytophage.com

本社

Oak Bluff, Canada

設立

-

Cytophage Technologies Ltd is listed in the Healthcare sector of the トロントベンチャー取引所 with ticker CYTO. The last closing price for Cytophage Technologies was $0.01. Over the last year, Cytophage Technologies shares have traded in a share price range of $ 0.005 to $ 0.32.

Cytophage Technologies currently has 64,886,733 shares in issue. The market capitalisation of Cytophage Technologies is $324,433.67 .

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.005	0.005	0.005	0	0	CS
4	-0.015	-75	0.02	0.045	0.005	355557	0.00895728	CS
12	-0.075	-93.75	0.08	0.095	0.005	197980	0.0229472	CS
26	-0.17	-97.1428571429	0.175	0.19	0.005	113809	0.04119855	CS
52	-0.19	-97.4358974359	0.195	0.32	0.005	79848	0.09750205	CS
156	-0.645	-99.2307692308	0.65	0.76	0.005	71736	0.23950369	CS
260	-0.645	-99.2307692308	0.65	0.76	0.005	71736	0.23950369	CS

CYTO - Frequently Asked Questions (FAQ)

What is the current Cytophage Technologies Ltd share price?

The current share price of Cytophage Technologies Ltd is $ 0.005

How many Cytophage Technologies Ltd shares are in issue?

Cytophage Technologies Ltd has 64,886,733 shares in issue

What is the market cap of Cytophage Technologies Ltd?

The market capitalisation of Cytophage Technologies Ltd is CAD 324.43k

What is the 1 year trading range for Cytophage Technologies Ltd share price?

Cytophage Technologies Ltd has traded in the range of $ 0.005 to $ 0.32 during the past year

What is the registered address of Cytophage Technologies Ltd?

The registered address for Cytophage Technologies Ltd is 400 Fort Whyte Way, Oak Bluff, Manitoba, R4G 0B1

What is the Cytophage Technologies Ltd website address?

The website address for Cytophage Technologies Ltd is cytophage.com

Which industry sector does Cytophage Technologies Ltd operate in?

Cytophage Technologies Ltd operates in the Biotechnology & Life Sciences sector

ProfitScout

ProfitScout 2分前

$DPRO News: Draganfly Announces Date of Annual General Meeting and Slate of Directors

Vancouver, BC., June 05, 2026 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems d

WhatMoney?

WhatMoney? 2分前

Did you do the update? There's a new one out amd my version is now 1.3.34 and bloomberg is completely gone.

BlazingStocks

BlazingStocks 3分前

There is a difference between acquiring technology and building an ecosystem.
NUBURU appears focused on the latter.
By utilizing Lyocon as the implementation vehicle for this cooperation, $BURU is reinforcing its strategy of assembling complementary capabilities within its own operatin

peafunke

peafunke 3分前

Still no update in iOS. 1.3.31. Any sign of a payment system ?

Wallstreeter$$$

Wallstreeter$$$ 3分前

Biased opinions based on you losing big ain't facts goofball.

BottomBounce

BottomBounce 3分前

🌍 Global Hydrogen Market Value (2026)
Most major energy analysts estimate the global hydrogen market at:

✅ $180–$210 billion today

(depending on whether you include industrial hydrogen + green hydrogen + infrastructure)

This includes:

BottomBounce

BottomBounce 3分前

🌍 Global Hydrogen Market Value (2026)
Most major energy analysts estimate the global hydrogen market at:

✅ $180–$210 billion today

(depending on whether you include industrial hydrogen + green hydrogen + infrastructure)

This includes:

CryptoRain

CryptoRain 3分前

Good lord..barely any volume.

boston127

boston127 4分前

Down 30% on volume of 250 shares.

Not 2,500 or 250,000 - $2.50 caused this drop.

Werbe

Okay here is the original note with HLLK and Traderverse. It IS NOT BACKED by any particular assets but does give HLLK, now VGLS, the rights to go after the company for court costs associated with suits so we have that locked down. I am sure they will demand and sue unless they just want to flout

ducci1

H of a Short Day !!----Take Care Chief !!

Buckey

I think we have a big correction coming and I am also bearish Spacex then again I was TESLA also and still am. Hope to live long enough to be proven right

learningcurve2020

learningcurve2020 4分前

Something you all inexplicably ignore to no ends is the rejection of the L pediatric trial. Remember that? LP told us it was all set to go then it was pulled. 🤷‍♀️

WeeZuhl

WeeZuhl 4分前

It will be larger than Vyvanse is for elite.

https://investorshub.advfn.com/uimage/uploads/2026/6/5/[dilrELTP_Investors.jpg

Lime Time

Lime Time 5分前

Shell status change from 'N' to 'Y'

FeMike

I think you are mixing normal steps of the process with a significant event of getting rejection recommendation of the only product the company is actively developing and the only approval they have applied for . And what they have directly or indirectly implied in ASM , and in individual shareholde

ducci1

Bloomberg-----Jobs Report Way High------Talking Raising Interest Rates! Boom Down She Goes !

Moneysign5

Moneysign5 6分前

Bloomberg+ works for me

boston127

boston127 6分前

Major setback here in price.

Hopefully, the company is doing well and the price will rebound.

Lone Clone

Lone Clone 6分前

Generic Gold Announces Entering into Definitive Agreements to Sell Yukon Exploration Portfolio

https://www.newsfilecorp.com/release/300046/Generic-Gold-Announces-Entering-into-Definitive-Agreements-to-Sell-Yukon-Exploration-Portfolio

June 03, 2026 6:00 PM EDT | Source:

MartinLutherKing

MartinLutherKing 7分前

À Savy Whale Hit is Imminent.. Piranhas will hit the Ask before the chase$$$$$

Luis Andros

Luis Andros 7分前

The quantum computing boom is currently unfolding in a multi-stage rollout, with massive commercial viability and widespread market impact projected to peak between 2028 and 2032. - McKinsey (Quantum Experts)

Near-Term Breakthroughs (2027-2028): Analysts and industry leaders, includi

lighter than AIR

lighter than AIR 7分前

If a flipper can step in and sell shares, which stops any upward momentum…that wasn’t much of a move in the first place. You give him too much credit. Piles of dirt, uprooted signs, where the PPS is now…will all be meaningless when the news hits…IF the news hits. Either these talks of contracts a

learningcurve2020

learningcurve2020 7分前

Precisely. It’s not a decision. Just the other day disciples were arguing that just because CHM pans a MAA isn’t a guarantee of rejection. She knows this and will take it to the very end. This assumes an actual letter was ever produced, of course. 🤷‍♀️

>>I can't imagine a C

Cytophage Technologies

Samsung Electronics

HSBC MSCI USA Climate Pa...

UBS JP Morgan USD EM Div...

Zinzino AB publ

Elbit Medical Technologies (GM)

100 UCITS ETF ACC Exchan... (ID)

China Everbright Environ...

Banestes Recebiveis Imob...

Terra Innovatum Global NV

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。